Evidence map›Paper›PMID 41194498›Full record

ArticleParasitology2025

Using precision mapping of schistosomiasis to guide female genital schistosomiasis (FGS) screening in Cameroon, sub-Saharan Africa.

Louis-Albert Tchuem Tchuenté, Nestor Feussom Gipwe, Emmanuelle Yimgoua, Vanessa Christinet, Jutta Reinhard-Rupp, J Russell Stothard

Abstract read
In one paragraph

Article in Parasitology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Louis-Albert Tchuem TchuentéCentre for Schistosomiasis and Parasitology, University of Yaoundé I, Yaoundé, Cameroon.ORCID https://orcid.org/0000-0001-7365-7650
Nestor Feussom GipweCentre for Schistosomiasis and Parasitology, University of Yaoundé I, Yaoundé, Cameroon.
Emmanuelle YimgouaCentre for Schistosomiasis and Parasitology, University of Yaoundé I, Yaoundé, Cameroon.
Vanessa ChristinetASCRES, Association de Soutien aux Centres de Recherches, d'Enseignements et de Soins, Geneva, Switzerland.
Jutta Reinhard-RuppFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
J Russell StothardDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID https://orcid.org/0000-0002-9370-3420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis remains a significant public health concern in sub-Saharan Africa, particularly among women and children. In Cameroon, urogenital and intestinal schistosomiasis affect the lives of millions of impoverished populations, and female genital schistosomiasis (FGS) remains a serious threat which has not been quantified explicitly. The extent of stigmatization and discrimination related to FGS is currently unknown. This study explores the use of precision mapping to identify high-risk communities for urogenital schistosomiasis and guide targeted screening for FGS. Parasitological surveys were conducted between November 2020 and July 2021 in four health districts using urine filtration and Kato-Katz techniques, first in schools to identify areas of higher transmission, and secondly in selected high-risk communities. Geographic information system tools were employed to identify high transmission foci and households of targeted infected women. Results of surveys in schools showed no schistosomiasis transmission in Ayos (0%) and low prevalence in Akonolinga (8%), while Bertoua and Doume had high prevalence, up to 33% and 48% infection with

Indexed as

Mass ScreeningSchistosomiasis haematobiaAdolescentAdultAnimalsCameroonChildFemaleHumansMiddle AgedPrevalenceSchistosoma haematobiumYoung AdultCameroonfemale genital schistosomiasisgeospatial analysisprecision mappingschistosomiasis

Identifiers

PMID41194498
PMCPMC13121902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.